← Human Trials & Peer-Reviewed Studies
Impact of Vitamin D Supplementation on Attention-Deficit Hyperactivity Disorder in Children.
Plain-language guide to PMID 29457493 (2018): controlled clinical trial of Vitamin D, K2, Magnesium and Zinc in 50 children.
Key Facts
- PMID
- 29457493
- Journal
- The Annals of pharmacotherapy
- Year
- 2018
- Study type
- Controlled Clinical Trial
- Authors
- Elshorbagy HH et al. (9 authors)
- DOI
- 10.1177/1060028018759471
What This Study Did, in Plain Language
What Was Tested
The paper reports a study of Vitamin D, K2, Magnesium and Zinc, published as a controlled clinical trial.
The primary objective was to evaluate the serum vitamin D level in children with a diagnosis of ADHD.
The secondary objective was to detect the effect of vitamin D supplementation on cognitive function in those with vitamin D deficiency.
Why It Was Studied
The role of nutrients and dietary factors in attention-deficit hyperactivity disorder (ADHD) remains unclear.
Who Took Part
The abstract describes 50 children taking part.
The age groups tagged for this paper are children and teenagers, both men and women.
A total of 50 children with ADHD and 40 healthy controls were included in the study.
Patients with vitamin D deficiency were subdivided into 2 groups: one with vitamin D supplementation and the other without vitamin D supplementation.
How the Study Was Run
The researchers measured the serum level of vitamin D.
Further assessment and follow-up of children with ADHD was done.
The Wisconsin Card Sorting Test, Conners' Parent Rating Scale, and Wechsler Intelligence Scale for Children were performed at baseline and follow-up in all cohorts with an ADHD diagnosis.
What Was Measured
The subject headings attached to it are Attention Deficit Disorder with Hyperactivity, Cognition, Dietary Supplements, Vitamin D, Vitamin D Deficiency and Vitamins.
Author keywords: ADHD, children and supplementation.
What This Means in Plain Language
This is a controlled clinical trial of Vitamin D, K2, Magnesium and Zinc in 50 children.
Its findings take up roughly 4 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.
The publication is from 2018 (The Annals of pharmacotherapy), a journal based in United States.
More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.
Our Notes on the Compound
Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.